TY  - GEN
AU  - O'Sullivan,Ciara C
AU  - Connolly,Roisin M
TI  - Pertuzumab and its accelerated approval: evolving treatment paradigms and new challenges in the management of HER2-positive breast cancer
SN  - 0890-9091
PY  - 2014///0618
KW  - Animals
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacokinetics
KW  - Antineoplastic Agents
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Drug Approval
KW  - Female
KW  - Humans
KW  - Molecular Targeted Therapy
KW  - Neoadjuvant Therapy
KW  - Receptor, ErbB-2
KW  - antagonists & inhibitors
KW  - Signal Transduction
KW  - drug effects
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
ER  -